Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Arcus Biosciences, Inc. (RCUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 21,369 shares @ $19.99, valued at $427.2k
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Azoy Alexander (Chief Accounting Officer) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 1,018 shares @ $20.41, valued at $20.8k
06/30/2023 4 GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 1,010,000 shares @ $19.26, valued at $19.5M
06/16/2023 4 Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Disposed/sold 2,892 shares @ $19.35, valued at $56k
06/16/2023 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 12,563 shares @ $19.35, valued at $243.1k
06/16/2023 4 Jaen Juan C. (President) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Gifted 6,000 shares @ $0
Disposed/sold 4,820 shares @ $19.35, valued at $93.3k
06/16/2023 4 ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Disposed/sold 8,762 shares @ $19.35, valued at $169.5k
06/16/2023 4 Lambert Nicole (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 PERLMAN ANDREW J (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 Lacey David L. (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 Ribas Antoni (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 KANEKO YASUNORI (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/16/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Gifted 50,504 shares @ $0
Granted 6,800 shares @ $0
Granted 19,500 options to buy @ $19.6, valued at $382.2k
06/09/2023 4 Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 4,049 shares @ $20.04, valued at $81.1k
03/20/2023 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 8,729 shares @ $16.81, valued at $146.7k
03/10/2023 3 Azoy Alexander (Chief Accounting Officer) has filed a Form 3 on Arcus Biosciences, Inc.
01/30/2023 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 300 shares @ $23.56, valued at $7.1k
Sold 1,600 shares @ $23.52, valued at $37.6k
01/25/2023 4 Nuyten Dimitry SA (Chief Medical Officer) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 34,000 shares @ $0
Granted 138,200 options to buy @ $22.02, valued at $3M
01/25/2023 4 Goeltz II Robert C. (CFO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 34,000 shares @ $0
Granted 138,200 options to buy @ $22.02, valued at $3M
01/25/2023 4 Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 34,000 shares @ $0
Granted 138,200 options to buy @ $22.02, valued at $3M
01/25/2023 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 45,800 shares @ $0
Granted 185,900 options to buy @ $22.02, valued at $4.1M
01/25/2023 4 Jaen Juan C. (President) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 45,800 shares @ $0
Granted 185,900 options to buy @ $22.02, valued at $4.1M
01/25/2023 4 ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 105,700 shares @ $0
Granted 429,000 options to buy @ $22.02, valued at $9.4M
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 ROSEN TERRY J (CEO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 10,983 shares @ $30.66, valued at $336.7k
Sold 2,060 shares @ $31.23, valued at $64.3k
09/20/2022 4 Jarrett Jennifer (COO) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 12,677 shares @ $26.28, valued at $333.2k
08/24/2022 4 Nuyten Dimitry SA (Chief Medical Officer) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Granted 42,500 shares @ $0
Granted 170,000 options to buy @ $26, valued at $4.4M
08/08/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2022 4 Tang Carolyn C. (General Counsel) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Sold 1,400 shares @ $20.72, valued at $29k
Sold 449 shares @ $21.71, valued at $9.7k
Sold 1,073 shares @ $22.29, valued at $23.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy